news and resources |
press releasesSeries A Funding Apneon obtained $5.1 million in Series A funding in August of 2003 from Frazier HealthCare Ventures and Split Rock Partners (formerly St. Paul Venture Capital). In less than 18 months, with less than $2 million in expenditures, Apneon reached the milestone of their first human clinical procedure. Series B Funding Apneon subsequently raised $12 million in Series B funding in September 2005. This round of funding was led by Pequot Ventures and included Cutlass Capital, Frazier HealthCare Ventures and Split Rock Partners. |
